|
Q3 FY2017
As of Jun 30, 2017
|
Q2 FY2017
As of Mar 31, 2017
|
Q1 FY2017
As of Dec 31, 2016
|
Q4 FY2016
As of Sep 30, 2016
|
Q3 FY2016
As of Jun 30, 2016
|
Q2 FY2016
As of Mar 31, 2016
|
Q1 FY2016
As of Dec 31, 2015
|
Q4 FY2015
As of Sep 30, 2015
|
Q3 FY2015
As of Jun 30, 2015
|
Q2 FY2015
As of Mar 31, 2015
|
Q1 FY2015
As of Dec 31, 2014
|
Q4 FY2014
As of Sep 30, 2014
|
Q3 FY2014
As of Jun 30, 2014
|
Q2 FY2014
As of Mar 31, 2014
|
Q1 FY2014
As of Dec 31, 2013
|
Q4 FY2013
As of Sep 30, 2013
|
Q3 FY2013
As of Jun 30, 2013
|
Q2 FY2013
As of Mar 31, 2013
|
Q1 FY2013
As of Dec 31, 2012
|
Q4 FY2012
As of Sep 30, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Receivables, net of allowances of $1,324 at June 30, 2017 and $1,296 at September 30, 2016 | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Deferred income tax assets - current | ||||||||||||||||||||
| Prepaid income taxes | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Land and improvements | ||||||||||||||||||||
| Buildings and improvements | ||||||||||||||||||||
| Internal software | ||||||||||||||||||||
| Equipment | ||||||||||||||||||||
| Property, plant and equipment, at cost | ||||||||||||||||||||
| Less accumulated depreciation and amortization | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Equity in joint ventures | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net of accumulated amortization of $12,704 at June 30, 2017 and $11,772 at September 30, 2016 | ||||||||||||||||||||
| Dosimetry devices, net of accumulated depreciation of $6,845 at June 30, 2017 and $6,197 at September 30, 2016 | ||||||||||||||||||||
| Deferred income tax assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Deferred contract revenue | ||||||||||||||||||||
| Accrued compensation and related costs | ||||||||||||||||||||
| Accrued severance (Note 3) | ||||||||||||||||||||
| Accrued severance | ||||||||||||||||||||
| Other accrued expenses | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Pension and postretirement obligations | ||||||||||||||||||||
| Deferred income tax liabilities | ||||||||||||||||||||
| Uncertain income tax liabilities | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock, $0.10 par value per share, authorized 20,000,000 shares; 9,811,668 and 9,727,264 shares issued and outstanding at June 30, 2017 and September 30, 2016, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Landauer, Inc. stockholders' equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity | ||||||||||||||||||||
Loading...
